Related Experiment Video

Updated: Jul 7, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

The bacterial envelope as a target for novel anti-MRSA antibiotics

Françoise Van Bambeke1, Marie-Paule Mingeot-Leclercq, Marc J Struelens

  • 1Université Catholique de Louvain, Unité de Pharmacologie Cellulaire et Moléculaire, UCL 7370 Avenue Mounier 73, 1200 Brussels, Belgium. francoise.vanbambeke@uclouvain.be

Trends in Pharmacological Sciences
|February 12, 2008
PubMed

Insights

New antibiotics targeting bacterial membranes, like lipopeptides and lipoglycopeptides, show promise against resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). These agents offer rapid bacterial killing and may reduce resistance development.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Rising global prevalence of antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
  • Urgent need for novel antibiotics targeting new bacterial mechanisms to combat resistance.
  • Bacterial membrane-targeting agents show potential due to rapid bactericidal effects and reduced resistance selection pressure.

Purpose of the Study:

  • To review novel anti-MRSA agents that disrupt bacterial membrane integrity.
  • To discuss the mode of action, pharmacological properties, and clinical applications of these agents.
  • To evaluate the potential of membrane-targeting antibiotics in combating resistant Staphylococcus aureus infections.

Main Methods:

  • Literature review of ceragenins, lipopeptides, lipoglycopeptides, and glycodepsipeptides.
  • Analysis of their mechanisms of action, focusing on bacterial membrane disruption.
  • Evaluation of their efficacy, safety profiles, and spectrum of activity against resistant S. aureus.

Main Results:

  • Lipopeptides and lipoglycopeptides demonstrate efficacy in treating skin infections and bacteremia caused by resistant S. aureus.
  • Ceragenins and glycodepsipeptides are limited to topical use due to safety concerns.
  • These agents function by disturbing bacterial membrane integrity, leading to rapid cell death.

Conclusions:

  • Antibiotics targeting bacterial membrane integrity represent a promising strategy against MRSA and VISA.
  • Lipopeptides and lipoglycopeptides are effective for systemic and topical applications.
  • Further research into ceragenins and glycodepsipeptides may be warranted for topical treatments.

More Related Videos

MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria08:34

MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria

Published on: February 23, 2021

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...